Breast cancer scientists, clinicians, patient advocates, and other health care professionals will converge this December for the 46th annual San Antonio Breast Cancer Symposium®, the preeminent international symposium for breast cancer research.
Join more than 9,500 attendees from around the world December 5-9 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, for the latest advances in scientific research, diagnosis, treatment, and patient advocacy. Register today and take advantage of early registration pricing.
The 2023 SABCS® Program Committee has developed a cutting-edge educational program, with everything from clinical workshops and special sessions to case discussions and controversies. Topics range from biology, etiology, and prevention to diagnosis and novel therapies of breast cancer and premalignant breast disease. There is something for everyone with a special interest in breast cancer, from patient advocacy to cellular therapy.
Here are a few highlights from the 2023 SABCS® program:
- New drug approvals for metastatic breast cancer
- Prevention, early detection, and intervention
- Social determinants of health and the impact on cancer care
Clinical workshop on tumor-agnostic approaches to care
- Agnostic trials in the field of targeted therapies
- Antibody-drug conjugate (ADC) development across tumor types
- Real-world data
- Defining a biologic entity that is sensitive to immunotherapeutics
Translational research controversies
- Low-dose tamoxifen (baby-TAM)
- When to do a window trial
- Are we sequencing too late?
- Coordinated care of brain metastases
- Lobular breast cancer
- Overcoming obesity-associated breast cancer risk
- Treatment post-cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors
This year’s debate topic is Anthracyclines: To give or not to give? chaired by Harold J. Burstein, MD, PhD, Dana-Farber Cancer Institute, and debated by Martine J. Piccart, MD, PhD, Institut Jules Bordet, Brussels; and Virginia F. Borges, MD, University of Colorado School of Medicine.
This year’s People’s Choice educational session will be on Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts, and Novel Treatments.
Many of those highlights can be found on the first day of the symposium, and there is so much more packed into the following days: poster spotlights, debates, and clinical and translational and controversies sessions, along with 11 educational sessions.
The plenary lectures feature Charles Swanton, MD, PhD, The Francis Crick Institute, who will address tumor heterogeneity and evolution in breast cancer; and Melinda Telli, MD, Stanford University School of Medicine, who will discuss recent advances in triple-negative breast cancer.
The 2023 SABCS® will also spotlight surgical and radiation oncology, with sessions covering topics including demystifying the axilla, patient-friendly radiation courses with whole breast irradiation (WBI) and partial breast irradiation (PBI), surgical management of clinical stage I HER2-positive and triple-negative breast cancer, and breast reconstruction technique and timing after mastectomy.
This year, the symposium will feature new State-of-the-Art Sessions taking the place of Forums, as well as abstracts from all-new categories, new career development workshops, and a new location for posters (click here to find out more about what’s new this year). Attendees will also experience sessions that are popular year after year, including awards lectures, poster spotlights, and the Year in Review. The wrap-up session View from the Trenches: What Will You Do on Monday Morning? gives attendees a launching point to take what they learned back to their labs and practices for optimal effect.
SABCS® packs the latest in breast cancer science, research, and treatment into five days you won’t forget, so register today—you don’t want to miss it!
Be sure to check out SABCS Meeting News before, during, and after the conference for the latest Symposium news, updates, and information.